NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Da Silva Graça Amoras, Ednelza ^a   Gomes, Samara Tatielle Monteiro ^a   Freitas, Felipe Bonfim ^a   Santana, Bárbara Brasil ^a   Ishak, Geraldo ^a   De Araújo, Marialva Tereza Ferreira ^a   Demachki, Sâmia ^a   Da Silva Conde, Simone Regina Souza ^a,b   De Oliveira Guimarães Ishak, Marluísa ^a   Ishak, Ricardo ^a   Vallinoto, Antonio Carlos Rosário ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Hepatology Outpatient Service   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; NGF PROTEIN, HUMAN; NGFR PROTEIN, HUMAN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE EXPRESSION; GENE FUNCTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER REGENERATION; MALE; NGF GENE; P75NTR GENE; REGULATORY MECHANISM; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; LIVER; LIVER CIRRHOSIS; PATHOLOGY; UPREGULATION; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; NERVE GROWTH FACTOR; NERVE TISSUE PROTEINS; RECEPTORS, NERVE GROWTH FACTOR; UP-REGULATION;

EID: 84929497502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121754     Document Type: Article

References (41)

1. Aguilera Guirao A, Romero Yuste S, Regueiro BJ. Epidemiology and clinical manifestations of viral hepatitis. Enferm Infecc Microbiol Clin. 2006;24:264-276. PMID: 16725087
2. Alter MJ. Epidemiology of hepatitis C virus infections. World J Gastroenterol. 2006;13:2436-2441.
3. Mita E, Hayashi N, Iio S, Takehara T, Hijioka T, Kasahara A, et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun. 1994;204:468-474. PMID: 7980502
4. Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005;54:1024-1033. PMID: 15951554
5. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010;90:1165-1194. doi: 10.1152/physrev. 00061.2009 PMID: 20664081
6. Benyon RC, Iredale JP. Is liver fibrosis reversible? Gut 2000;46:443-446. PMID: 10716665
7. Gäbele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci. 2003;8:d69-d77. PMID: 12456323
8. Zaman A, Rosen HR, Ingram K, Corless CL, Oh E, Smith K. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. Am J Med. 2007;120:280.e9-14. PMID: 17349453
9. Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatol. 1994;20:15-20.
10. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095-2100. PMID: 14697814
11. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC, Trent Hepatitis C Study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004;53:451-455. PMID: 14960533
12. Cohen S, Levi-Montalcini R, Hamburger V. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc Natl Acad Sci U S A. 1954;40:1014-1018. PMID: 16589582
13. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951;116:321-361. PMID: 14824426
14. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217-1281. PMID: 11520933
15. Trim N, Morgan S, Evans M, Issa R, Fine D, Afford S, et al. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol. 2000;156:1235-1243. PMID: 10751349
16. Oakley F, Trim N, Constandinou CM, Ye W, Gray AM, Frantz G, et al. Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol. 2003;16:1849-1858.
17. Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007;315:1853-1856. PMID: 17395831
18. Asai K, Tamakawa S, Yamamoto M, Yoshie M, Tokusashi Y, Yaginuma Y, et al. Activated hepatic stellate cells overexpress p75NTR after partial hepatectomy and undergo apoptosis on nerve growth factor stimulation. Liver Int. 2006;26:595-603. PMID: 16762005
19. Kendall TJ, Hennedige SA, Aucott RL, Hartland S N N, Vernon MA, Benyon RC, et al. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatol. 2009;49:901-910.
20. Gayotto LC. Comitê SBP-SBH. Visão histórica e consenso nacional sobre a classificação das hepatites crônicas [Historical vision and national consensus on the classification of chronic hepatitis]. Project of the Liver Pathology Club of the Brazilian society of pathology approved by the Brazilian Society of Hepatology. GED Gastroenterol Endosc Dig. 2000;19:137-140.
21. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatol. 1996;24:289-293.
22. Ayres M, Ayres M, Ayres DL, Santos AS. BioEstat 5.0: Aplicações estatísticas nas áreas de ciências biológicas e médicas [BioEstat 5.0: statistical applications in biological and medical sciences]. Belém: Sociedade Civil Mamirauá, 2008.
23. GraphPad Software Inc. Prism (data analysis software system), version 5. Software e Guia do Usuário, 2007.
24. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836-847. PMID: 15459664
25. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis. 2001;21:437-451. PMID: 11586471
26. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther. 1995;66:387-412. PMID: 7667403
27. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterol. 1998;95:734-739.
28. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44-48. PMID: 9448172
29. Uyama N, Shimahara Y, Kawada N, Seki S, Okuyama H, Limuro Y, et al. Regulation of cultured rat hepatocyte proliferation by stellate cells. J Hepatol. 2002;36:590-599. PMID: 11983441
30. Oakley F, Teoh V, Ching-A-Sue G, Bataller R, Colmenero J, Josson JR, et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterol. 2009;136:2334-2344.e.1. doi: 10.1053/j.gastro.2009.02.081 PMID: 19303015
31. Novo E, Marra F, Zamara E, Valfrè di Bonzo L, Monitillo L, Cannito S, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-1182. PMID: 16423888
32. Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterol. 2004;126:529-540.
33. Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp Mol Med. 2005;37:138-145. PMID: 15886528
34. London RM, George J. Pathogenesis of NASH: animal models. Clin Liver Dis. 2007;11:55-74, viii. PMID: 17544972
35. Ikejima K, Okumura K, Kon K, Takei Y, Sato N. Role of adipocytokines in hepatic fibrogenesis. J Gastroenterol Hepatol. 2007;22(Suppl 1):S87-S92. PMID: 17567476
36. Ikejima K, Takei Y, Honda H, Hirose M, Yoshikawa M, Zhang YJ, et al. Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterol. 2002;122:1399-1410.
37. Lin S, Saxena NK, Ding X, Stein LL, Anania FA. Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol. 2006;20:3376-3388. PMID: 16931573
38. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol. 2002;37:206-213. PMID: 12127425
39. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterol. 2003;125:1796-1807.
40. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterol. 2004;126:586-597.
41. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 2001;35:297-306. PMID: 11580156